ATHX : Summary for Athersys, Inc. - Yahoo Finance

U.S. Markets close in 3 hrs 33 mins

Athersys, Inc. (ATHX)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.14+0.01 (+0.58%)
As of 12:27PM EDT. Market open.
People also watch
CURCYTXPSTIOPXACYCC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.13
Open1.13
Bid1.13 x 4800
Ask1.14 x 1000
Day's Range1.12 - 1.14
52 Week Range1.02 - 2.69
Volume170,059
Avg. Volume791,636
Market Cap124.79M
Beta-0.27
PE Ratio (TTM)-6.28
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Athersys, Inc. :ATHX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube4 days ago

    Athersys, Inc. :ATHX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Athersys, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Athersys, Inc. – Vericel Corporation, Amgen Inc., Johnson & Johnson, Bristol-Myers Squibb Company, Sanofi Sponsored ADR, Pfizer Inc. and Arena Pharmaceuticals, Inc. (VCEL-US, AMGN-US, JNJ-US, BMY-US, SNY-US, PFE-US and ... Read more (Read more...)

  • GlobeNewswire4 days ago

    Two New Publications Highlight the Potential for MultiStem® Treatment of Ischemic Stroke

    CLEVELAND, March 20, 2017-- Athersys, Inc. announced today that clinical investigators have published results from Athersys’ Phase 2 trial of MultiStem cell therapy for treating ischemic stroke patients ...

  • Athersys, Inc. :ATHX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube9 days ago

    Athersys, Inc. :ATHX-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis Athersys, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Athersys, Inc. – Vericel Corporation, Amgen Inc., Johnson & Johnson, Pfizer Inc., Sanofi Sponsored ADR, Bristol-Myers Squibb Company, RTI Surgical, Inc. and Arena Pharmaceuticals, Inc. (VCEL-US, AMGN-US, JNJ-US, PFE-US, ... Read more (Read more...)